Cutler Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $507K | Sell |
61,300
-275,500
| -82% | -$25.6M | 0.17% | 133 |
|
|
2023
Q4 | $2.62M | Buy |
336,800
+231,100
| +219% | +$17.2M | 0.23% | 95 |
|
|
2023
Q3 | $287K | Sell |
105,700
-56,500
| -35% | -$4.51M | 0.03% | 609 |
|
|
2023
Q2 | $1.13M | Buy |
162,200
+67,200
| +71% | +$5.62M | 0.16% | 150 |
|
|
2023
Q1 | $1.04M | Sell |
95,000
-122,500
| -56% | -$10.2M | 0.11% | 197 |
|
|
2022
Q4 | $451K | Sell |
217,500
-29,000
| -12% | -$2.35M | 0.04% | 481 |
|
|
2022
Q3 | $473K | Sell |
246,500
-565,200
| -70% | -$47.6M | 0.03% | 550 |
|
|
2022
Q2 | $1.73M | Buy |
811,700
+108,800
| +15% | +$8.17M | 0.12% | 212 |
|
|
2022
Q1 | $1.12M | Sell |
702,900
-447,200
| -39% | -$41.3M | 0.06% | 354 |
|
|
2021
Q4 | $745K | Buy |
1,150,100
+837,700
| +268% | +$101M | 0.03% | 568 |
|
|
2021
Q3 | $359K | Sell |
312,400
-22,700
| -7% | -$2.92M | 0.02% | 976 |
|
|
2021
Q2 | $922K | Sell |
335,100
-166,100
| -33% | -$21.8M | 0.04% | 482 |
|
|
2021
Q1 | $1.63M | Buy |
501,200
+303,800
| +154% | +$45.5M | 0.08% | 274 |
|
|
2020
Q4 | $1.06M | Sell |
197,400
-102,500
| -34% | -$13.1M | 0.05% | 379 |
|
|
2020
Q3 | $633K | Sell |
299,900
-54,800
| -15% | -$6.14M | 0.04% | 459 |
|
|
2020
Q2 | $2.1M | Buy |
354,700
+12,600
| +4% | +$1.24M | 0.14% | 149 |
|
|
2020
Q1 | $184K | Buy |
342,100
+177,500
| +108% | +$15.7M | 0.01% | 999 |
|
|
2019
Q4 | $878K | Sell |
164,600
-69,300
| -30% | -$5.99M | 0.05% | 287 |
|
|
2019
Q3 | $70K | Sell |
233,900
-11,600
| -5% | -$964K | 0.01% | 1306 |
|
|
2019
Q2 | $795K | Buy |
245,500
+9,200
| +4% | +$785K | 0.07% | 232 |
|
|
2019
Q1 | $326K | Buy |
236,300
+40,700
| +21% | +$3.46M | 0.03% | 450 |
|
|
2018
Q4 | $403K | Buy |
195,600
+68,700
| +54% | +$5.54M | 0.04% | 402 |
|
|
2018
Q3 | $1.15M | Sell |
126,900
-166,200
| -57% | -$16.1M | 0.08% | 232 |
|
|
2018
Q2 | $1.65M | Buy |
293,100
+80,700
| +38% | +$7.42M | 0.13% | 158 |
|
|
2018
Q1 | $1.1M | Sell |
212,400
-53,400
| -20% | -$4.88M | 0.1% | 207 |
|
|
2017
Q4 | $2M | Sell |
265,800
-359,400
| -57% | -$30.1M | 0.08% | 174 |
|
|
2017
Q3 | $4.16M | Sell |
625,200
-85,200
| -12% | -$6.83M | 0.16% | 96 |
|
|
2017
Q2 | $3.85M | Buy |
710,400
+81,400
| +13% | +$5.77M | 0.14% | 123 |
|
|
2017
Q1 | $1.44M | Buy |
629,000
+263,200
| +72% | +$17.7M | 0.06% | 269 |
|
|
2016
Q4 | $415K | Sell |
365,800
-79,700
| -18% | -$4.92M | 0.01% | 792 |
|
|
2016
Q3 | $1.48M | Buy |
445,500
+97,600
| +28% | +$6.04M | 0.07% | 216 |
|
|
2016
Q2 | $512K | Buy |
347,900
+1,400
| +0.4% | +$76.7K | 0.03% | 584 |
|
|
2016
Q1 | $682K | Sell |
346,500
-120,700
| -26% | -$6.27M | 0.04% | 397 |
|
|
2015
Q4 | $837K | Buy |
+467,200
| New | +$31.9M | 0.05% | 398 |
|
Other funds holding XBI
ACA
Cutler Group's XBI Position: Q1 2024 in Review
Cutler Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2024, closing a stake of 62,433 shares — an estimated $5.79M sold.
Cutler Group first reported a position in XBI in Q4 2015 and held it in 28 quarters. The position peaked at $10.7M in Q1 2022. 780 funds tracked by Wall St. Rank hold XBI as of Q1 2024.
- Cutler Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2024 after selling out during the quarter.
- Cutler Group sold 62,433 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $5.79M.
- Cutler Group first reported a position in State Street SPDR S&P Biotech ETF in Q4 2015 and held it in 28 quarters.
- Cutler Group's State Street SPDR S&P Biotech ETF position peaked at $10.7M in Q1 2022.
- 780 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.
Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.